Technology
Health
Biotechnology

T2 Biosystems

$2.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.34%) Today
-$0.01 (-0.34%) Today

Why Robinhood?

You can buy or sell T2 Biosystems and other stocks, options, ETFs, and crypto commission-free!

About

T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. Read More It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.

Employees
153
Headquarters
Lexington, Massachusetts
Founded
2006
Market Cap
128.55M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
629.44K
High Today
$2.90
Low Today
$2.86
Open Price
$2.90
Volume
10.47K
52 Week High
$9.98
52 Week Low
$2.47

Collections

Technology
Health
Biotechnology
2014 IPO
US
North America

News

Seeking AlphaMar 21

T2 Bio up 20% on GE supply deal

T2 Biosystems (TTOO +20.3% ) is up on more than double normal volume in response to its agreement with GE Healthcare under which the latter will supply its superparamagnetic particles for use with TTOO's products.

79
Seeking AlphaMar 8

T2 Biosystems, Inc. (TTOO) CEO John McDonough on Q4 2018 Results - Earnings Call Transcript

T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2018 Results Earnings Conference Call March 8, 2019 4:30 PM ET Company Participants Zack Kubow - Investor Contact, W2O Group John McDonough - Chief Executive Officer John Sprague - Chief Financial Officer Conference Call Participants Stephen Brozak - WBB Securities Max Masucci - Canaccord Genuity Patrick Donnelly - Goldman Sachs Paul Knight - Janney Capital Markets Jordan Abrams - Cantor Fitzgerald Soumit Roy - JonesTrading Edward Marks - HC Wainwright Punee...

519
MarketBeatMar 7

Stock Price, News, & Analysis for T2 Biosystems

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States. It provides T2 Magnetic Resonance platform that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company also offers T2Dx, a bench-top instrument for sepsis, Lyme disease, and other applications, as well as T2Candida panel for the detection of candida ...

154

Earnings

-$0.51
-$0.42
-$0.34
-$0.25
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.